Iranian experience of deferasirox (Exjade®) in transfusion-dependent patients with iron overload: what is the most effective dose based on serum ferritin levels?-Reference-Cited by-同舟云学术

Iranian experience of deferasirox (Exjade®) in transfusion-dependent patients with iron overload: what is the most effective dose based on serum ferritin levels?

Published:2012-11 Issue:6 Volume:17 Page:367-371
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Karimi Mehran¹,Azarkeivan Azita²,Zareifar Soheila¹,Cohan Nader¹,Bordbar Mohammad Reza¹,Haghpanah Sezaneh¹

Affiliation:

1. Hematology Research CenterShiraz University of Medical Sciences, Shiraz, Iran

2. Iranian Blood Transfusion OrganizationTehran, Iran

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1179/1024533212Z.000000000143

Reference22 articles.

1. Practical management of iron overload

2. Hematopoietic stem cell transplantation for β-thalassemia major: Experience in south of Iran

3. Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone

4. The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterisation of individual ferritin response in patients receiving chelation therapy;British Journal of Clinical Pharmacology;2022-03-26

2. Comparison of Magnetic Resonance Imaging T2 Results in Beta-Thalassemia Patients Treated by Deferasirox or Combination of Deferoxamine and Deferiprone;Iranian Journal of Pediatric Hematology & Oncology;2020-10-21

3. The Zinc and Copper Levels in Thalassemia Major Patients, Receiving Iron Chelation Therapy;Journal of Pediatric Hematology/Oncology;2018-04

4. A 3-year study of deferasirox therapy in sickle cell disease patients in Basra, Southern Iraq;Nigerian Journal of Clinical Practice;2018

5. Evaluation of Proteinuria in β-Thalassemia Major Patients With and Without Diabetes Mellitus Taking Deferasirox;Journal of Pediatric Hematology/Oncology;2017-01